Paul Tudor Jones's G Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 328,285 shares of Genpact Limited (G) worth $9.03 M, representing 0.01% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in G, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2026, adding 328,285 shares. Largest reduction occurred in Q2 2022, reducing 300,765 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Genpact Limited (G) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genpact Limited (G) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +328,285 | New Buy | 328,285 | $27.50 |
| Q4 2025 | -73,125 | Sold Out | 0 | $0.00 |
| Q3 2025 | -188,421 | Reduce 72.04% | 73,125 | $41.89 |
| Q2 2025 | -112,816 | Reduce 30.14% | 261,546 | $44.01 |
| Q1 2025 | +89,867 | Add 31.59% | 374,362 | $50.38 |
| Q4 2024 | +284,495 | New Buy | 284,495 | $42.95 |
| Q3 2024 | -90,423 | Sold Out | 0 | $0.00 |
| Q2 2024 | -69,932 | Reduce 43.61% | 90,423 | $32.19 |
| Q1 2024 | +125,731 | Add 363.13% | 160,355 | $32.95 |
| Q4 2023 | +34,624 | New Buy | 34,624 | $34.71 |
| Q1 2023 | -20,959 | Sold Out | 0 | $0.00 |
| Q4 2022 | +20,959 | New Buy | 20,959 | $0.05 |
| Q2 2022 | -300,765 | Sold Out | 0 | $0.00 |
| Q1 2022 | +68,908 | Add 29.72% | 300,765 | $43.51 |
| Q4 2021 | +56,497 | Add 32.22% | 231,857 | $53.08 |
| Q3 2021 | +55,571 | Add 46.39% | 175,360 | $47.51 |
| Q2 2021 | +96,906 | Add 423.48% | 119,789 | $45.43 |
| Q1 2021 | -110,839 | Reduce 82.89% | 22,883 | $42.83 |
| Q4 2020 | +92,613 | Add 225.29% | 133,722 | $41.36 |
| Q3 2020 | +41,109 | New Buy | 41,109 | $38.95 |
| Q1 2020 | -111,041 | Sold Out | 0 | $0.00 |
| Q4 2019 | -23,297 | Reduce 17.34% | 111,041 | $42.17 |
| Q3 2019 | +89,839 | Add 201.89% | 134,338 | $38.75 |
| Q2 2019 | +16,050 | Add 56.42% | 44,499 | $38.09 |
| Q1 2019 | +10,927 | Add 62.36% | 28,449 | $35.19 |
| Q4 2018 | +17,522 | New Buy | 17,522 | $26.99 |
| Q3 2018 | -41,689 | Sold Out | 0 | $0.00 |
| Q2 2018 | +19,935 | Add 91.64% | 41,689 | $28.93 |
| Q1 2018 | -31,475 | Reduce 59.13% | 21,754 | $31.99 |
| Q4 2017 | -4,617 | Reduce 7.98% | 53,229 | $31.73 |
| Q3 2017 | -96 | Reduce 0.17% | 57,846 | $28.75 |
| Q2 2017 | -65,650 | Reduce 53.12% | 57,942 | $27.84 |
| Q1 2017 | +17,450 | Add 16.44% | 123,592 | $24.76 |
| Q4 2016 | +22,296 | Add 26.59% | 106,142 | $24.34 |
| Q3 2016 | +25,646 | Add 44.07% | 83,846 | $23.95 |
| Q2 2016 | -45,471 | Reduce 43.86% | 58,200 | $26.84 |
| Q1 2016 | +79,681 | Add 332.14% | 103,671 | $27.19 |
| Q4 2015 | -12,051 | Reduce 33.44% | 23,990 | $24.97 |
| Q3 2015 | -16,458 | Reduce 31.35% | 36,041 | $23.61 |
| Q2 2015 | +43,580 | Add 488.62% | 52,499 | $21.33 |
| Q1 2015 | -4,134 | Reduce 31.67% | 8,919 | $23.21 |
| Q4 2014 | -11,949 | Reduce 47.79% | 13,053 | $18.92 |
| Q3 2014 | +9,737 | Add 63.79% | 25,002 | $16.32 |
| Q2 2014 | +15,265 | New Buy | 15,265 | $17.56 |
| Q1 2014 | -40,862 | Sold Out | 0 | $0.00 |
| Q4 2013 | +20,762 | Add 103.29% | 40,862 | $18.38 |
| Q3 2013 | +20,100 | New Buy | 20,100 | $18.86 |
Paul Tudor Jones's Genpact Limited Investment FAQs
Paul Tudor Jones first purchased Genpact Limited (G) in Q3 2013, acquiring 20,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Genpact Limited (G) for 47 quarters since Q3 2013.
Paul Tudor Jones's largest addition to Genpact Limited (G) was in Q2 2026, adding 328,285 shares worth $9.03 M.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 328,285 shares of Genpact Limited (G), valued at approximately $9.03 M.
As of the Q2 2026 filing, Genpact Limited (G) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Genpact Limited (G) was 374,362 shares, as reported at the end of Q1 2025.